ClawScore · Drug Licensing
How to Check Drug-Licensing Litigation Exposure of a Company in India (2026)
For any company in pharmaceuticals, from a manufacturer to a distributor or a stockist, its drug licence is the licence to exist, and a regulatory action against it is both a compliance and a commercial risk. Drug-licensing exposure runs through the Drugs and Cosmetics Act, 1940, and splits in two: administrative action by the licensing authority on the one hand, and criminal prosecution for quality offences on the other. Neither always shows in a general court search, so they are easy to miss. This guide explains where drug-licensing matters surface and how to read them before a credit or deal decision. Last verified October 2026.
- Two tracks: administrative licence action by the State Drugs Controller or CDSCO under the Drugs and Cosmetics Act, 1940, and criminal prosecution for quality offences in court.
- Check both layers: the regulator for licence actions, recalls and alerts, and the court records for prosecutions.
- Matters attach to units and products: search the plant and product names, not just the head entity.
- Read the nature: a spurious or adulterated-drug matter or a cancelled licence is far sharper than a procedural notice.
01The short answer
To check a company's drug-licensing exposure, look at two tracks under the Drugs and Cosmetics Act, 1940. The administrative track is the licensing authority, the State Drugs Controller and the Central Drugs Standard Control Organisation (CDSCO), which issue licences and can suspend or cancel them, with an appeal to the state government. The criminal track is prosecution in court for offences such as manufacturing or selling substandard, adulterated, misbranded or spurious drugs, which carry serious penalties. Search the company name on the court records for prosecutions, and check the regulator for licence actions and recall or alert notices.
Confirm the company name, the manufacturing-unit names and the corporate identity number first, since a licence action often attaches to a specific unit or product.
02The two tracks of drug-licensing risk
The two tracks read very differently and need to be checked separately:
- Administrative action. The licensing authority can issue a show cause notice and suspend or cancel a licence for a breach, with an appeal to the state government.
- Criminal prosecution. For quality offences, the state drug authorities prosecute in court. Offences involving adulterated or spurious drugs are treated as serious; see adulteration of drugs under the criminal law.
A licence suspension can stop production immediately, while a prosecution runs in the background and can take years, so the two carry different operational and reputational weight.
03Where the exposure shows
Drug-licensing exposure sits across the regulator and the court records:
| Source | What it shows | Where |
|---|---|---|
| State Drugs Controller | Licence suspension, cancellation and show cause actions | State drug control portals |
| CDSCO | Recall, alert and not-of-standard-quality notices | cdsco.gov.in |
| Criminal courts | Prosecutions for quality and licensing offences | eCourts and High Court portals |
| High Courts | Writs and appeals touching on licence actions | eCourts and High Court portals |
Because licence actions are administrative, a serious regulatory problem can exist as a suspension or a not-of-standard-quality alert without being a court case, so the picture needs both the regulator and the court records.
04What the actions signal
Not every regulatory note is equal. Read for how directly it touches quality and the licence:
- A spurious or adulterated-drug matter is the sharpest signal, going to product safety and criminal liability.
- A licence suspension or cancellation is an operational stop, not just a fine.
- Repeated not-of-standard-quality alerts point to a systemic quality problem across batches.
- A single procedural notice, by contrast, may be routine for a large manufacturer.
05Reading a drug-licensing finding
Read a drug-licensing matter for its nature, the unit or product, the stage and the pattern:
- Nature: a quality or spurious-drug matter bites harder than a documentation breach.
- Unit or product: which plant or product is affected, and how central it is.
- Stage: a confirmed cancellation or a framed prosecution is harder than a show cause notice.
- Pattern: repeated actions across units or products point to a systemic problem.
A single procedural notice is routine for a large pharma company. A spurious-drug prosecution or a cancelled licence is a different story, and that is what the records are there to show.
06What a clean result actually means
A clean drug-licensing check means no matter was found on the records you searched, on the date you searched, under the names, units and corporate identity you used. It does not rule out a licence action at the administrative stage that is not yet a court case, a matter attached to a unit or product you did not search, a forum you did not reach, or a notice issued later. Any criminal prosecution carries the presumption of innocence until a court decides. Combine the regulator status with the court records, read the nature and the unit, record what you covered, and re-check before a credit or deal decision. This is research to inform a decision, not legal advice.
07Where Claw fits
Claw is an all-in-one legaltech platform for Indian advocates, law firms, and corporate legal teams, combining AI-based case search, an AI legal assistant (Legal GPT), case management, and compliance automation across all Indian courts and tribunals.
ClawScore, at clawscore.clawlaw.in, is Claw's litigation and criminal-risk intelligence service, and drug-licensing and quality prosecutions are one of the exposure types it surfaces in a single pass. You give it a company name and it searches every matter it finds across 9,102 courts, benches and forums, criminal courts and High Courts among them, and returns one scored Excel workbook: a Summary tab with a ClawScore risk band of Clean, Low, Moderate or High, a Matters tab, a Related parties tab that pulls in directors and group entities, and a Coverage tab recording what was searched. Every finding carries a match confidence, so a similar company or unit name is flagged for you to verify. Constant Monitoring runs daily, weekly or monthly scans on a watched entity list and reports what is New, Changed or Closed, so a fresh prosecution does not go unseen until the next review. It draws on 30 crore+ judgments, with Supreme Court decisions from 1950 and High Court decisions from 1990, and returns results in under 5 seconds. Claw does not use your searched names or documents to train its AI models. Because licence actions are administrative, you still check the State Drugs Controller and CDSCO records directly, any criminal matter is read with the presumption of innocence, and a Clean band means nothing was found in these registries on the date searched under the names searched. The band is a risk-triage signal, not a credit score and not legal advice.
Create a FREE Claw account to check a company and set up monitoring, and use case search across Indian courts to surface drug-quality and other matters against the company and its units.
08Sources and further reading
- Central Drugs Standard Control Organisation (drug regulation and alerts): cdsco.gov.in
- India Code (Drugs and Cosmetics Act, 1940, bare text): indiacode.nic.in
- eCourts (prosecutions and related court matters): ecourts.gov.in
- Claw: clawlaw.in
Government portals are the authoritative record. This guide is general information, not legal advice; confirm any licence action or prosecution on the official record before acting.
09Frequently asked questions
How do I check a company's drug-licensing exposure in India?
Look at two tracks under the Drugs and Cosmetics Act, 1940. Check the State Drugs Controller and CDSCO for licence suspension, cancellation, recall and not-of-standard-quality actions, and search the court records for prosecutions over substandard, adulterated or spurious drugs. Confirm the company name, unit names and CIN first, since actions often attach to a specific unit or product.
What is the difference between a licence action and a prosecution?
A licence action is administrative: the licensing authority can suspend or cancel a licence for a breach, with an appeal to the state government, and a suspension can stop production immediately. A prosecution is criminal: for quality offences the drug authorities prosecute in court, which runs in the background and can take years. They carry different operational and reputational weight and should be checked separately.
Which findings matter most?
A spurious or adulterated-drug matter is the sharpest signal, going to product safety and criminal liability. A licence suspension or cancellation is an operational stop. Repeated not-of-standard-quality alerts point to a systemic quality problem across batches. A single procedural notice may be routine for a large manufacturer.
Will a licence action show as a court case?
Not always. Licence suspension, cancellation and not-of-standard-quality alerts are administrative and may not appear as a court case. A matter reaches the court records mainly as a prosecution or on appeal, so you combine the regulator status with the court records.
Does a clean drug-licensing check mean the company is safe?
No. It means no matter was found on the records you searched, on the date you searched, under the names, units and CIN you used. It does not rule out a licence action at the administrative stage, a matter attached to an unsearched unit or product, a forum you did not reach, or a notice issued later. Any prosecution is read with the presumption of innocence. It is research to inform a decision, not legal advice.